The word peptide is not an approval status.
Peptide describes a type of molecule. Some peptide medicines are FDA-approved for specific uses; others remain investigational. Each formulation and intended use needs its own assessment.
Compounding is a separate question.
A compounded preparation is not FDA-approved. It does not inherit a branded product’s approval. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.
Off-label and unapproved are not synonyms.
Off-label generally describes use of an approved drug outside its approved labeling. It should not be used as a shortcut to describe an unapproved compound or imply that every peptide on a website is an approved medicine.
Read the safety information.
FDA has published ingredient-specific safety concerns for several peptides. Ask your clinician about human evidence, uncertainties, established alternatives, and the current requirements for the exact product being considered.
Educational information only. Product specifications are not dosing instructions.